Your browser doesn't support javascript.
loading
Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment.
Vuorio, Alpo; Kovanen, Petri T; Raal, Frederick J.
Affiliation
  • Vuorio A; Forensic Medicine, Mehiläinen Airport Health Centre, Vantaa, Finland.
  • Kovanen PT; Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
  • Raal FJ; Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland.
Ann Med ; 55(1): 2199218, 2023 12.
Article in En | MEDLINE | ID: mdl-37068045

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 / Anticholesteremic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Finlandia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 / Anticholesteremic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Finlandia Country of publication: Reino Unido